FDA’s Draft QMSR: 3 Experts Read More Stakeholder Comments So You Don’t Have To

Part Two Of Two

 
• By Shawn M. Schmitt

The second of two parts: Industry experts Vincent Cafiso, Kim Trautman and Dennis Gucciardo spoke with Medtech Insight about noteworthy comments on the US FDA’s proposed Quality Management System Regulation.

A stakeholder.
Stakeholders had their say on the FDA's proposed quality systems rule • Source: Shutterstock

More from Regulation

More from Policy & Regulation